Literature DB >> 4055782

Identification of a peptide fragment from the carboxyl-terminal extension region (E-domain) of rat proinsulin-like growth factor-II.

V W Hylka, D B Teplow, S B Kent, D S Straus.   

Abstract

A fragment of the carboxyl-terminal extension region (E-peptide) of rat proinsulin-like growth factor-II has been purified from medium conditioned by cultured BRL-3A rat liver cells. The fragment, identified by microsequence analysis, was discovered in a biologically active fraction of insulin-like growth factor II (IGF-II). The fragment begins at position 117 in pro-IGF-II, two amino acids downstream from an Arg-Arg potential prohormone processing site. A synthetic analogue of the E-peptide at high concentrations stimulates [3H]thymidine incorporation in NIL8 hamster cells, raising the possibility that the E-peptide might bind with low affinity to a mitogen receptor. Peptides from the E-regions of pro-IGF-I and pro-IGF-II should be useful for development of radioimmunoassays for measurement of the somatic production of IGF-I and IGF-II, analogous to the radioimmunoassay for the insulin C-peptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055782

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion.

Authors:  C M Buchanan; A R Phillips; G J Cooper
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

2.  Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.

Authors:  A Morrione; B Valentinis; S Q Xu; G Yumet; A Louvi; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.

Authors:  Daniel S Straus
Journal:  Mol Cancer       Date:  2013-07-17       Impact factor: 27.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.